Harwood Feffer LLP Announces Investigation of Illumina Inc.

NEW YORK--(BUSINESS WIRE)--Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) concerning the proposed acquisition of the Company by Roche Holding AG (“Roche”) in a transaction valued at approximately $5.7 billion.

On January 25, 2012, Roche announced that it offered to acquire all of Illumina’s outstanding shares for $44.50 per share. Roche will put the offer directly to shareholders after it said in a statement that Illumina management was “unwilling to participate in substantive discussions.”

The offer price represents a scant 18% premium over the closing price on January 24, 2012 and Illumina stock is presently trading above $52.00 per share.

Our investigation concerns whether the board of directors is fulfilling its fiduciary duties, maximizing the value of Illumina, disclosing all material benefits and costs and obtaining full and fair consideration for Illumina shareholders.

If you own Illumina shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Benjamin Sachs-Michaels
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers:	[phone]
	[phone]
Email: [e-mail]
Website: http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.